Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.

Ribaudo HJ, Liu H, Schwab M, Schaeffeler E, Eichelbaum M, Motsinger-Reif AA, Ritchie MD, Zanger UM, Acosta EP, Morse GD, Gulick RM, Robbins GK, Clifford D, Haas DW
J Infect Dis. 2010 202 (5): 717-22

PMID: 20662624 · PMCID: PMC2919241 · DOI:10.1086/655470

MeSH Terms (21)

Alkynes Anti-HIV Agents Aryl Hydrocarbon Hydroxylases ATP Binding Cassette Transporter, Subfamily B ATP Binding Cassette Transporter, Subfamily B, Member 1 Benzoxazines Blacks Cyclopropanes Cytochrome P-450 CYP2B6 Cytochrome P-450 CYP3A Female Hispanic or Latino HIV Infections Humans Male Oxidoreductases, N-Demethylating Pharmacogenetics Polymorphism, Single Nucleotide Reverse Transcriptase Inhibitors Treatment Outcome Whites

Connections (1)

This publication is referenced by other Labnodes entities: